- Home
- SCNI vs ALBT Comparison
SCNI vs ALBT Comparison
Compare SCNI & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- ALBT
- Stock Information
- Founded
- SCNI 2003
- ALBT 2014
- Country
- SCNI Israel
- ALBT United States
- Employees
- SCNI N/A
- ALBT N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SCNI Health Care
- ALBT Health Care
- Exchange
- SCNI Nasdaq
- ALBT Nasdaq
- Market Cap
- SCNI 3.1M
- ALBT 3.1M
- IPO Year
- SCNI N/A
- ALBT N/A
- Fundamental
- Price
- SCNI $3.51
- ALBT $3.66
- Analyst Decision
- SCNI
- ALBT
- Analyst Count
- SCNI 0
- ALBT 0
- Target Price
- SCNI N/A
- ALBT N/A
- AVG Volume (30 Days)
- SCNI 8.1K
- ALBT 90.7K
- Earning Date
- SCNI 11-22-2024
- ALBT 11-12-2024
- Dividend Yield
- SCNI N/A
- ALBT N/A
- EPS Growth
- SCNI N/A
- ALBT N/A
- EPS
- SCNI 8.20
- ALBT N/A
- Revenue
- SCNI $452,000.00
- ALBT N/A
- Revenue This Year
- SCNI N/A
- ALBT N/A
- Revenue Next Year
- SCNI N/A
- ALBT N/A
- P/E Ratio
- SCNI $0.43
- ALBT N/A
- Revenue Growth
- SCNI N/A
- ALBT N/A
- 52 Week Low
- SCNI $2.23
- ALBT $2.11
- 52 Week High
- SCNI $8.92
- ALBT $21.60
- Technical
- Relative Strength Index (RSI)
- SCNI 52.75
- ALBT 51.99
- Support Level
- SCNI $3.41
- ALBT $3.20
- Resistance Level
- SCNI $3.80
- ALBT $3.81
- Average True Range (ATR)
- SCNI 0.18
- ALBT 0.41
- MACD
- SCNI -0.00
- ALBT -0.01
- Stochastic Oscillator
- SCNI 36.42
- ALBT 50.30
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.